Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of SMC3 mRNA | affects expression | 21346803
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of SMC3 mRNA | affects expression | 16483693
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of SMC3 mRNA | increases expression | 20504355
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SMC3 mRNA | decreases expression | 20382639 20018196
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of SMC3 mRNA | decreases expression | 20106945
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of SMC3 mRNA | decreases expression | 15834898
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of SMC3 mRNA | increases expression | 18035473
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in decreased expression of SMC3 mRNA | decreases expression | 16221955
|
C058305 |
phenethyl isothiocyanate |
phenethyl isothiocyanate results in decreased expression of SMC3 mRNA | decreases expression | 17616710
|
D010758 |
Phosphorus |
Phosphorus results in increased expression of SMC3 mRNA | increases expression | 17715259
|
D013654 |
Taurine |
Taurine results in increased expression of SMC3 mRNA | increases expression | 16579726
|
C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of SMC3 mRNA | affects expression | 17440010
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of SMC3 mRNA | decreases expression | 18691609
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.96 | 11752688 14514962 15322242 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.68 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.08 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.24 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.24 | 14692618 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.70 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.49 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.02 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.18 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.57 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.71 | 15885639 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.12 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.92 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.81 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.89 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.89 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.86 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
1.77 | 16705839 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.07 | 20419170 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.41 | 18850075 18670907 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
11.46 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
11.46 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
11.46 | 12371664 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.23 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.98 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
7.98 | 17681005 16919318 17110522 11677210 16105132 17333356 15861022 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.13 | 16354765 15668235 8697196 15340226 12621046 |
MESH:D003093 |
Colitis, Ulcerative |
|
phenethyl isothiocyanate |
3.67 | 20423518 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.13 | 17141729 14669216 |
MESH:C536443 |
Cornelia de Lange syndrome 3 |
marker/mechanism |
|
| |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 10048152 20055451 15322242 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.12 | 18551238 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.68 | 17107852 |
MESH:D058065 |
Diabetic Cardiomyopathies |
|
Taurine |
6.17 | 16025228 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.51 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Taurine |
6.51 | 9328219 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.51 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.82 | 11462148 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
7.21 | 17259670 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.21 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.04 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.28 | 12538720 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.10 | 9294722 10568697 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.41 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.41 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.07 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
7.85 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
7.85 | 15345470 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.56 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.83 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.83 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.34 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.73 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.58 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.58 | 10048152 11294989 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.54 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.42 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
9.02 | 3609246 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
9.02 | 12621046 15340226 16120746 |
MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
5.88 | 17440010 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.18 | 18606429 8697196 15340226 16959395 16354765 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
3.92 | 12083418 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.04 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.04 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.91 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.55 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.54 | 17937319 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
8.64 | 17296493 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
8.64 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
8.64 | 12200463 12878042 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.42 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.58 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.38 | 18776723 10903974 8314463 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
7.50 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.50 | 12371664 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
5.35 | 8812269 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Taurine |
2.86 | 15931870 15893842 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.86 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
10.95 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
10.95 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
10.95 | 18709148 14757943 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
10.95 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
5.90 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.90 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
2.20 | 20135361 20464547 6695378 18816296 18569708 17053015 20064080 18520028 20869020 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.20 | 19555203 11884234 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.92 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.25 | 16381670 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.08 | 12213967 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.98 | 7678174 18551238 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.20 | 11141357 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.58 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.36 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.31 | 14600291 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
5.06 | 9802331 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.51 | 16049721 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.77 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.38 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.65 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.29 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
10.07 | 17132714 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
10.07 | 11118676 11896295 11399792 11222880 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.96 | 17292933 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.43 | 15861022 16919318 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.25 | 16882103 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.93 | 18990726 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.59 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.59 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.59 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.08 | 16709447 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 2093021 20155912 |
MESH:D013733 |
Testicular Diseases |
|
phenethyl isothiocyanate |
5.06 | 15864552 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.71 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.22 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.04 | 12697716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.07 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.07 | 17053015 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.43 | 10091137 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.39 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.12 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.73 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.62 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.38 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.58 | 17120751 |